Identification of Pattern and Factors Affecting Recurrence in Head and Neck Carcinoma
Launched by SOHAG UNIVERSITY · Jun 16, 2024
Trial Information
Current as of June 26, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is looking into how and why head and neck cancer sometimes comes back after treatment. Researchers will review past treatment experiences to find out how often the cancer returns and where it tends to come back in the body, as well as what factors may influence these recurrences. The goal is to better understand this type of cancer to improve future treatments.
To participate, you need to be an adult over 18 years old who has been diagnosed with a specific type of head and neck cancer (not including nasopharyngeal cancer) and has received certain types of advanced radiation therapy. Unfortunately, those with multiple cancers or advanced cases where the cancer has spread to other parts of the body cannot join. If you qualify, you will help researchers gather valuable information that could lead to better care for future patients facing similar challenges.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Adults aged more than 18 years. Patients with primary non nasopharyngeal head and neck squamous cell carcinoma. Patients who were intended to receive radical treatment delivered by IMRT and VMAT techniques.
- Exclusion Criteria:
- • Adults who had double malignancies. Metastatic HNSCC cases.
About Sohag University
Sohag University is a distinguished academic institution located in Sohag, Egypt, committed to advancing healthcare through rigorous clinical research. As a clinical trial sponsor, the university leverages its robust infrastructure and multidisciplinary expertise to facilitate innovative studies aimed at improving patient outcomes and contributing to the global body of medical knowledge. With a focus on ethical standards and scientific integrity, Sohag University collaborates with healthcare professionals and researchers to conduct trials that address critical health issues, ensuring the advancement of evidence-based practices in the healthcare community.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Sohag, , Egypt
Sohag, , Egypt
Patients applied
Trial Officials
Reem Gamal, M.B.B.Ch
Principal Investigator
Sohag university hospital, oncology and nuclear medicine department
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported